Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,200
-1.54%
|
$138,600
$63.89 P/Share
|
|
Dec 02
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+1.52%
|
$22,000
$10.6 P/Share
|
|
Dec 02
2025
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
8,750
-10.5%
|
$551,250
$63.9 P/Share
|
|
Dec 02
2025
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+9.5%
|
$87,500
$10.0 P/Share
|
|
Dec 01
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
28,064
-73.77%
|
$1,852,224
$66.72 P/Share
|
|
Dec 01
2025
|
Edward M. Md Kaye Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,064
+32.67%
|
$364,832
$13.33 P/Share
|
|
Dec 01
2025
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
2,150
-10.39%
|
$141,900
$66.8 P/Share
|
|
Nov 19
2025
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-17.9%
|
$320,000
$64.73 P/Share
|
|
Nov 18
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,200
-1.54%
|
$145,200
$66.45 P/Share
|
|
Nov 18
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+1.52%
|
$22,000
$10.6 P/Share
|
|
Nov 14
2025
|
Jeffrey Hessekiel Chief Legal & Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,297
+50.0%
|
-
|
|
Nov 11
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
5,175
-34.15%
|
$336,375
$65.08 P/Share
|
|
Nov 11
2025
|
Edward M. Md Kaye Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,175
+25.46%
|
$46,575
$9.66 P/Share
|
|
Nov 05
2025
|
Robert I Blum President & CEO |
SELL
Bona fide gift
|
Direct |
2,000
-0.56%
|
-
|
|
Nov 04
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,295
-1.61%
|
$135,405
$59.55 P/Share
|
|
Nov 04
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,295
+1.58%
|
$22,950
$10.6 P/Share
|
|
Oct 30
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$310,000
$62.86 P/Share
|
|
Oct 27
2025
|
Wendell Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,375
-11.88%
|
$253,750
$58.68 P/Share
|
|
Oct 27
2025
|
Wendell Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+10.62%
|
$43,750
$10.0 P/Share
|
|
Oct 21
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,105
-1.48%
|
$122,090
$58.22 P/Share
|
|
Oct 21
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,105
+1.45%
|
$21,050
$10.6 P/Share
|
|
Oct 16
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.36%
|
$300,000
$60.03 P/Share
|
|
Oct 15
2025
|
Wendell Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.3%
|
$6,138
$62.8 P/Share
|
|
Oct 15
2025
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+1.96%
|
$12,338
$62.8 P/Share
|
|
Oct 15
2025
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+0.45%
|
$20,956
$62.8 P/Share
|
|
Oct 15
2025
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+0.95%
|
$12,338
$62.8 P/Share
|
|
Oct 15
2025
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.32%
|
$6,138
$62.8 P/Share
|
|
Oct 07
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$120,000
$60.56 P/Share
|
|
Oct 07
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Oct 06
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
6,757
-40.86%
|
$405,420
$60.0 P/Share
|
|
Oct 01
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.34%
|
$275,000
$55.05 P/Share
|
|
Sep 30
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
6,695
-28.82%
|
$368,225
$55.08 P/Share
|
|
Sep 23
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$98,000
$49.28 P/Share
|
|
Sep 23
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Sep 15
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.32%
|
$245,000
$49.77 P/Share
|
|
Sep 09
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$102,000
$51.29 P/Share
|
|
Sep 09
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Sep 02
2025
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
6,756
-22.53%
|
$337,800
$50.0 P/Share
|
|
Sep 02
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.31%
|
$240,000
$48.76 P/Share
|
|
Sep 02
2025
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
2,150
-9.5%
|
$103,200
$48.67 P/Share
|
|
Aug 19
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$76,000
$38.31 P/Share
|
|
Aug 19
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Aug 15
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.29%
|
$190,000
$38.42 P/Share
|
|
Aug 05
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$72,000
$36.34 P/Share
|
|
Aug 05
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Jul 29
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.27%
|
$180,000
$36.45 P/Share
|
|
Jul 22
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$74,000
$37.47 P/Share
|
|
Jul 22
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Jul 15
2025
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
164
+0.53%
|
$6,232
$38.01 P/Share
|
|
Jul 15
2025
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
559
+0.75%
|
$21,242
$38.01 P/Share
|